GUGLIESI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 3.972
EU - Europa 2.474
AS - Asia 1.683
SA - Sud America 140
AF - Africa 91
OC - Oceania 33
Totale 8.393
Nazione #
US - Stati Uniti d'America 3.917
IT - Italia 955
CN - Cina 511
SG - Singapore 482
IE - Irlanda 260
SE - Svezia 238
DE - Germania 176
AT - Austria 175
GB - Regno Unito 127
FR - Francia 104
BR - Brasile 101
FI - Finlandia 99
KR - Corea 94
JP - Giappone 88
IN - India 84
HK - Hong Kong 81
UA - Ucraina 76
ID - Indonesia 66
SA - Arabia Saudita 66
VN - Vietnam 61
SN - Senegal 48
CA - Canada 47
BE - Belgio 46
NL - Olanda 46
PL - Polonia 42
TR - Turchia 35
TW - Taiwan 27
AU - Australia 26
GR - Grecia 20
IL - Israele 20
CO - Colombia 18
DK - Danimarca 17
IR - Iran 17
PK - Pakistan 17
ES - Italia 16
RU - Federazione Russa 14
NO - Norvegia 13
UG - Uganda 12
CH - Svizzera 10
AR - Argentina 9
HR - Croazia 7
MA - Marocco 7
NZ - Nuova Zelanda 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
LT - Lituania 6
MX - Messico 6
PH - Filippine 6
TH - Thailandia 6
TN - Tunisia 6
BD - Bangladesh 5
EC - Ecuador 5
JO - Giordania 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
CL - Cile 3
ET - Etiopia 3
LU - Lussemburgo 3
RO - Romania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
EG - Egitto 2
PT - Portogallo 2
RS - Serbia 2
ZM - Zambia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
TG - Togo 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 8.393
Città #
Chandler 679
Singapore 346
Santa Clara 270
Dublin 257
Beijing 160
Vienna 156
Fairfield 150
Houston 143
Torino 137
Ann Arbor 120
Sovicille 115
Ashburn 105
Turin 105
Nyköping 95
Woodbridge 83
Columbus 82
Jacksonville 82
Seattle 78
Wilmington 75
Dearborn 70
Jakarta 66
Cambridge 60
Princeton 60
Medford 58
Villeurbanne 58
Pisa 50
Guangzhou 48
Los Angeles 45
Redwood City 45
Dong Ket 44
Rome 42
New York 39
Fremont 38
Milan 38
Boston 36
Jeddah 35
Warsaw 33
Hefei 32
Shanghai 32
Boardman 27
Lappeenranta 26
Washington 24
Brussels 22
Pittsburgh 22
Mumbai 21
Hong Kong 20
Frankfurt am Main 19
Taipei 18
Helsinki 17
Nanjing 17
Tokyo 17
Florence 16
Munich 16
San Mauro Torinese 16
Gongju 15
Norwalk 15
Orange 15
San Diego 14
Ta'if 14
Rochester 13
Aarhus 12
Baltimore 12
Hebei 12
Kampala 12
London 12
Maddaloni 12
Bogotá 11
Lahore 11
Philadelphia 11
Piemonte 11
Dallas 10
Istanbul 10
Seoul 10
Thebes 10
Toronto 10
Cardiff 9
Novara 9
Nuremberg 9
Oslo 9
Silver Spring 9
Tampa 9
The Dalles 9
Birmingham 8
Chicago 8
Hangzhou 8
Phoenix 8
Tel Aviv 8
Central 7
Hanover 7
Hyderabad 7
Ipswich 7
Kahramanmaraş 7
Medina 7
San Francisco 7
Stockholm 7
Wuhan 7
Alessandria 6
Antwerp 6
Atlanta 6
Berlin 6
Totale 4.907
Nome #
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 333
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 309
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 270
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 251
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 245
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 210
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 202
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 199
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 194
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 186
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 178
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 168
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 160
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 152
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 152
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 141
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 141
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 139
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 136
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 134
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 130
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 128
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 126
Where do we stand after decades of studying human cytomegalovirus? 124
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 123
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 121
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 118
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 115
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 114
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 111
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 105
Tuning the Orchestra: HCMV vs. Innate Immunity. 104
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 103
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 103
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 99
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 96
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 95
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 88
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 86
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 84
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 84
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 84
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 81
The interferon-inducible IFI16 gene acts as a restriction factor for human citomegalovirus replication 81
Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. 81
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 79
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 78
45th International Herpesvirus Workshop 77
Detection of IFI16 in body fluids 75
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 74
The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. 74
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 74
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 73
Targeting PAD-mediated citrullination to treat human papillomavirus infections 73
Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene 69
Biotechnology, Industry and Research in Piemonte from 1990 to 2003 : an update 68
Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha 68
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 68
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 67
50° Congresso Nazionale della Società Italiana di Microbiologia 66
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding 64
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 63
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 62
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 57
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 53
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 50
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 49
Targeting PAD-mediated citrullination to treat human papillomavirus infections 49
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 48
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 48
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 45
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 43
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 41
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 37
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 37
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 36
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 36
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 35
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer 27
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 22
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 21
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection 21
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 20
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 20
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 19
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 14
Totale 8.584
Categoria #
all - tutte 27.212
article - articoli 0
book - libri 0
conference - conferenze 16.575
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 0 0 0 0 0 0 0 0 0 46 64
2020/2021726 53 42 32 41 62 57 83 52 60 88 42 114
2021/2022835 65 22 53 82 35 30 32 35 35 63 234 149
2022/20231.853 99 109 29 237 201 423 91 152 268 55 89 100
2023/20241.039 142 154 74 51 90 105 49 68 22 65 82 137
2024/20252.010 83 267 222 210 406 180 140 137 143 142 80 0
Totale 8.584